Compile Data Set for Download or QSAR
Report error Found 61 Enz. Inhib. hit(s) with all data for entry = 50014046
TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572134(CHEMBL4868363)
Affinity DataKi:  0.200nMAssay Description:Inhibition of human partial length TAF1 bromodomain 2 (D1521 to D1656 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572127(CHEMBL4850335)
Affinity DataKi:  0.398nMAssay Description:Inhibition of human partial length TAF1 bromodomain 2 (D1521 to D1656 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572130(CHEMBL4864027)
Affinity DataKi:  0.794nMAssay Description:Inhibition of human partial length TAF1 bromodomain 2 (D1521 to D1656 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572131(CHEMBL4873236)
Affinity DataKi:  1nMAssay Description:Inhibition of human partial length TAF1 bromodomain 2 (D1521 to D1656 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572133(CHEMBL4854161)
Affinity DataKi:  1.30nMAssay Description:Inhibition of human partial length TAF1 bromodomain 2 (D1521 to D1656 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572127(CHEMBL4850335)
Affinity DataIC50: 32nMAssay Description:Inhibition of TAF1 bromodomain 2 (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572129(CHEMBL4860188)
Affinity DataIC50: 32nMAssay Description:Inhibition of TAF1 bromodomain 2 (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572130(CHEMBL4864027)
Affinity DataKi:  40nMAssay Description:Inhibition of human partial length BRD9 (R130 to V259 residues) expressed in bacterial expression system measured by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572130(CHEMBL4864027)
Affinity DataIC50: 40nMAssay Description:Inhibition of TAF1 bromodomain 2 (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572123(CHEMBL4878541)
Affinity DataIC50: 50nMAssay Description:Inhibition of TAF1 bromodomain 2 (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572132(CHEMBL4874167)
Affinity DataKi:  50nMAssay Description:Inhibition of human partial length TAF1 bromodomain 2 (D1521 to D1656 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572122(CHEMBL4865495)
Affinity DataIC50: 79nMAssay Description:Inhibition of TAF1 bromodomain 2 (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572137(CHEMBL4868318)
Affinity DataKd:  79nMAssay Description:Binding affinity to wild type TAF1 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50096308(CHEMBL3585461)
Affinity DataIC50: 158nMAssay Description:Inhibition of TAF1 bromodomain 2 (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572135(CHEMBL4871251)
Affinity DataKi:  200nMAssay Description:Inhibition of human partial length TAF1 bromodomain 2 (D1521 to D1656 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50096300(CHEMBL3585452)
Affinity DataIC50: 200nMAssay Description:Inhibition of TAF1 bromodomain 2 (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572120(CHEMBL4855456)
Affinity DataIC50: 316nMAssay Description:Inhibition of TAF1 bromodomain 2 (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572126(CHEMBL4856376)
Affinity DataIC50: 398nMAssay Description:Inhibition of TAF1 bromodomain 2 (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572121(CHEMBL4868866)
Affinity DataIC50: 501nMAssay Description:Inhibition of TAF1 bromodomain 2 (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetATPase family AAA domain-containing protein 2(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572129(CHEMBL4860188)
Affinity DataIC50: 631nMAssay Description:Inhibition of ATAD2 (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572125(CHEMBL4872504)
Affinity DataIC50: 631nMAssay Description:Inhibition of TAF1 bromodomain 2 (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572134(CHEMBL4868363)
Affinity DataKi:  631nMAssay Description:Inhibition of human partial length BRD4 BD1 (N44 to E168 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572133(CHEMBL4854161)
Affinity DataKi:  794nMAssay Description:Inhibition of human partial length BRD4 BD1 (N44 to E168 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572130(CHEMBL4864027)
Affinity DataKi:  794nMAssay Description:Inhibition of human partial length BRD4 BD2 (K333 to E460 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetBromodomain adjacent to zinc finger domain protein 2B(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572130(CHEMBL4864027)
Affinity DataKi:  1.00E+3nMAssay Description:Inhibition of human partial length BAZ2B (S2054 to S2168 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572124(CHEMBL4857270)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of TAF1 bromodomain 2 (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetChromatin remodeling regulator CECR2(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572130(CHEMBL4864027)
Affinity DataKi:  1.00E+3nMAssay Description:Inhibition of human partial length CECR2 (P423 to D543 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetATPase family AAA domain-containing protein 2(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572123(CHEMBL4878541)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of ATAD2 (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetATPase family AAA domain-containing protein 2(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572121(CHEMBL4868866)
Affinity DataIC50: 1.26E+3nMAssay Description:Inhibition of ATAD2 (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50096308(CHEMBL3585461)
Affinity DataIC50: 1.26E+3nMAssay Description:Inhibition of BRD4 BD1 (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetATPase family AAA domain-containing protein 2(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50096308(CHEMBL3585461)
Affinity DataIC50: 1.59E+3nMAssay Description:Inhibition of ATAD2 (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetATPase family AAA domain-containing protein 2(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50096300(CHEMBL3585452)
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of ATAD2 (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572136(CHEMBL4871450)
Affinity DataIC50: 2.00E+3nMAssay Description:Displacement of tetra-acetylated H4 peptide from GST-tagged TAF1 bromodomain 2 (unknown origin) incubated for 3 hrs by HTRF assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572127(CHEMBL4850335)
Affinity DataKi:  2.00E+3nMAssay Description:Inhibition of human partial length BRD4 BD1 (N44 to E168 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetATPase family AAA domain-containing protein 2(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572122(CHEMBL4865495)
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of ATAD2 (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572120(CHEMBL4855456)
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of BRD4 BD1 (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572124(CHEMBL4857270)
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of BRD4 BD1 (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572129(CHEMBL4860188)
Affinity DataIC50: 2.51E+3nMAssay Description:Inhibition of BRD4 BD1 (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetATPase family AAA domain-containing protein 2(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572120(CHEMBL4855456)
Affinity DataIC50: 2.51E+3nMAssay Description:Inhibition of ATAD2 (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50096300(CHEMBL3585452)
Affinity DataIC50: 2.51E+3nMAssay Description:Inhibition of BRD4 BD1 (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572121(CHEMBL4868866)
Affinity DataIC50: 2.51E+3nMAssay Description:Inhibition of BRD4 BD1 (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572123(CHEMBL4878541)
Affinity DataIC50: 2.51E+3nMAssay Description:Inhibition of BRD4 BD1 (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572132(CHEMBL4874167)
Affinity DataIC50: 3.16E+3nMAssay Description:Displacement of Halo-tagged histone H4 from NanoLuc-tagged TAF1 bromodomain 2 (unknown origin) expressed in HEK293 cells measured after 4 to 6 hrs by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetPeregrin(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572130(CHEMBL4864027)
Affinity DataKi:  5.01E+3nMAssay Description:Inhibition of human partial length BRPF1 (E627 to G740 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572130(CHEMBL4864027)
Affinity DataIC50: 5.01E+3nMAssay Description:Inhibition of BRD4 BD2 (unknown origin) measured by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572131(CHEMBL4873236)
Affinity DataKi: <5.01E+3nMAssay Description:Inhibition of human partial length BRD4 BD1 (N44 to E168 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572132(CHEMBL4874167)
Affinity DataKi: <5.01E+3nMAssay Description:Inhibition of human partial length BRD4 BD1 (N44 to E168 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572130(CHEMBL4864027)
Affinity DataKi: <5.01E+3nMAssay Description:Inhibition of human partial length BRD4 BD1 (N44 to E168 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572127(CHEMBL4850335)
Affinity DataIC50: 6.31E+3nMAssay Description:Inhibition of BRD4 BD1 (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572128(CHEMBL4862754)
Affinity DataIC50: 6.31E+3nMAssay Description:Inhibition of BRD4 BD1 (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
Displayed 1 to 50 (of 61 total ) | Next | Last >>
Jump to: